Find Research outputs

Search results

• 2020

  A modified delphi consensus study of the screening, diagnosis, and treatment of tardive dyskinesia

  Caroff, S. N., Citrome, L., Meyer, J., Sajatovic, M., Goldberg, J. F., Jain, R., Lundt, L., Lindenmayer, J. P., McEvoy, J. P., McIntyre, R. S., Tohen, M. & Ketter, T. A., Apr 1 2020, In: Journal of Clinical Psychiatry. 81, 2, 19cs12983.

  Research output: Contribution to journal › Article › peer-review

  • Delphi Technique
  • Tardive Dyskinesia
  • Consensus
  • Journal Impact Factor
  • Publications
  3 Scopus citations

• A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia

  Nakonezny, P. A., Lindow, J. C., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A. & Byerly, M. J., Jun 2020, In: Schizophrenia Research. 220, p. 92-97 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Antipsychotic Agents
  • Schizophrenia
  • Injections
  • ROC Curve
  • Area Under Curve

• Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

  McEvoy, J. P. & Kremens, D. E., Jan 28 2020, In: The Journal of clinical psychiatry. 81, 1

  Research output: Contribution to journal › Article › peer-review

  • Tardive Dyskinesia
  • Mood Disorders
  • Schizophrenia
  • Therapeutics

• Knowledge of HIV and HPV among women with serious mental illness

  Sanders, N., Miller, B., Hernandez-Morales, M. & McEvoy, J., Aug 2020, In: Psychiatric Services. 71, 8, p. 875 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Longitudinal study of inflammatory markers and psychopathology in schizophrenia

  Feng, T., McEvoy, J. P. & Miller, B. J., Oct 2020, In: Schizophrenia Research. 224, p. 58-66 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Psychopathology
  • Longitudinal Studies
  • Schizophrenia
  • Antipsychotic Agents
  • Linear Models

• The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures

  Kraus, M. S., Gold, J. M., Barch, D. M., Walker, T. M., Chun, C. A., Buchanan, R. W., Csernansky, J. G., Goff, D. C., Green, M. F., Jarskog, L. F., Javitt, D. C., Kimhy, D., Lieberman, J. A., McEvoy, J. P., Mesholam-Gately, R. I., Seidman, L. J., Ball, M. P., Kern, R. S., McMahon, R. P., Robinson, J. & 2 others, Marder, S. R. & Keefe, R. S. E., Mar 2020, In: Schizophrenia Research: Cognition. 19, 100161.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cognitive Neuroscience
  • Neuropsychological Tests
  • Psychometrics
  • Schizophrenia
  • Cognition
• 2019

  34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities

  Anderson, K. E., Stamler, D., Davis, M. D., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In: CNS spectrums. 24, 1, 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • deutetrabenazine
  • Tardive Dyskinesia
  • Dopamine Antagonists
  • Comorbidity
  • Abnormal Involuntary Movement Scale

• 35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia

  Anderson, K. E., Stamler, D., Davis, M. D., Gross, N., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In: CNS spectrums. 24, 1, p. 193-194 2 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • deutetrabenazine
  • Tardive Dyskinesia
  • Abnormal Involuntary Movement Scale
  • Placebos
  • Therapeutics

• A commentary on the efficacy of olanzapine for the treatment of schizophrenia: The past, present, and future

  Citrome, L., McEvoy, J. P., Todtenkopf, M. S., McDonnell, D. & Weiden, P. J., 2019, In: Neuropsychiatric Disease and Treatment. 15, p. 2559-2569 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Olanzapine
  • Antipsychotic Agents
  • Schizophrenia
  • Weight Gain
  • Therapeutics
  5 Scopus citations

• Characterizing treatment effects of valbenazine for tardive dyskinesia: Additional results from the KINECT 3 study

  Correll, C. U., Cutler, A. J., Kane, J. M., McEvoy, J. P., Liang, G. S. & O'Brien, C. F., Jan 2019, In: Journal of Clinical Psychiatry. 80, 1

  Research output: Contribution to journal › Article › peer-review

  • valbenazine
  • Abnormal Involuntary Movement Scale
  • Tardive Dyskinesia
  • Placebos
  • Body Regions
  3 Scopus citations

• Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

  McEvoy, J., Gandhi, S. K., Rizio, A. A., Maher, S., Kosinski, M., Bjorner, J. B. & Carroll, B., Dec 1 2019, In: Quality of Life Research. 28, 12, p. 3303-3312 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tardive Dyskinesia
  • Major Depressive Disorder
  • Bipolar Disorder
  • Schizophrenia
  • Quality of Life
  4 Scopus citations

• FDA-Approved Medications to Treat Tardive Dyskinesia

  McEvoy, J. P., Dec 17 2019, In: The Journal of clinical psychiatry. 81, 1

  Research output: Contribution to journal › Review article › peer-review

  • Tardive Dyskinesia
  • deutetrabenazine
  • valbenazine
  • Dopamine Receptors
  • Medication Adherence
  2 Scopus citations

• Heterogeneity of treatment effects of long-acting injectable antipsychotic medications

  Stroup, T. S., Bareis, N. A., Rosenheck, R. A., Swartz, M. S. & McEvoy, J. P., Jan 2019, In: Journal of Clinical Psychiatry. 80, 1

  Research output: Contribution to journal › Article › peer-review

  • haloperidol decanoate
  • Antipsychotic Agents
  • Paliperidone Palmitate
  • Injections
  • Substance-Related Disorders
  1 Scopus citations

• Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

  McEvoy, J. P., Dec 3 2019, In: The Journal of clinical psychiatry. 80, 6

  Research output: Contribution to journal › Article › peer-review

  • Tardive Dyskinesia
  • Mood Disorders
  • Schizophrenia
  • Antipsychotic Agents
  • Dopamine Receptors
  1 Scopus citations

• The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders

  McEvoy, J., Park, T., Schilling, T., Terasawa, E., Ayyagari, R. & Carroll, B., Jul 3 2019, In: Current Medical Research and Opinion. 35, 7, p. 1205-1214 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Tardive Dyskinesia
  • Mental Disorders
  • Antipsychotic Agents
  • Inpatients
  • Delivery of Health Care
  1 Scopus citations

• Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

  Kelly, C. W., McEvoy, J. P. & Miller, B. J., Jul 2019, In: Schizophrenia Research. 209, p. 193-197 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Clinical Trials, Phase I
  • Adipokines
  • Leukocyte Count
  • Metabolic Syndrome
  • Antipsychotic Agents
  2 Scopus citations

• Urinary tract infection, inflammation, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

  Thomas, J., McEvoy, J. P. & Miller, B. J., Nov 2019, In: Annals of Clinical Psychiatry. 31, 4, p. 242-248 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Clinical Trials, Phase I
  • Urinary Tract Infections
  • Antipsychotic Agents
  • Cognition
  • Inflammation
• 2018

  Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

  Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 others, Buckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In: Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Aripiprazole
  • Prolactin
  • Psychotic Disorders
  • Clinical Trials
  • Placebos
  5 Scopus citations

• Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels

  Wehring, H. J., Elsobky, T., McEvoy, J. P., Vyas, G., Richardson, C. M., McMahon, R. P., DiPaula, B. A., Liu, F., Sullivan, K., Buchanan, R. W., Feldman, S., McMahon, E. M. & Kelly, D. L., Mar 1 2018, In: Psychiatric Quarterly. 89, 1, p. 73-80 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Minocycline
  • Clozapine
  • Schizophrenia
  • Cytochrome P-450 CYP1A2
  • norclozapine
  9 Scopus citations

• Evidence-Based Strategies for Managing Tardive Dyskinesia

  McEvoy, J. P., Jan 1 2018, In: The Journal of clinical psychiatry. 79, 1

  Research output: Contribution to journal › Article › peer-review

  • Tardive Dyskinesia
  • Bipolar Disorder

• Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

  Miller, B. J., Buckley, P. F. & McEvoy, J. P., May 1 2018, In: Schizophrenia Research. 195, p. 275-282 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Marijuana Use
  • Clinical Trials, Phase I
  • Cocaine
  • Psychopathology
  • Antipsychotic Agents
  14 Scopus citations

• Revisiting the abnormal involuntary movement scale: Proceedings from the tardive dyskinesia assessment workshop

  Kane, J. M., Correll, C. U., Nierenberg, A. A., Caroff, S. N., Sajatovic, M., Cutler, A. J., McEvoy, J. P. & Stacy, M., May 1 2018, In: Journal of Clinical Psychiatry. 79, 3, 17cs11959.

  Research output: Contribution to journal › Article › peer-review

  • Abnormal Involuntary Movement Scale
  • Tardive Dyskinesia
  • Education
  • Minimal Clinically Important Difference
  • Telecommunications
  17 Scopus citations

• What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

  Manning, J. S. & McEvoy, J. P., Jan 1 2018, In: The Journal of clinical psychiatry. 79, 1

  Research output: Contribution to journal › Article › peer-review

  • Tardive Dyskinesia
  • Webcasts
  • Therapeutics
  1 Scopus citations
• 2017

  Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

  Anderson, K. E., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Isojärvi, J., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., McEvoy, J. P., Ochudlo, S., Ondo, W. G. & Fernandez, H. H., Aug 2017, In: The Lancet Psychiatry. 4, 8, p. 595-604 10 p.

  Research output: Contribution to journal › Article › peer-review

  • deutetrabenazine
  • Tardive Dyskinesia
  • Dyskinesias
  • Placebos
  • Abnormal Involuntary Movement Scale
  91 Scopus citations

• Prioritizing Harm

  Moyer, K. H., McEvoy, J. P., Mabe, P. A., Buchanan, E., Venkatesan, A. & Buckley, P. F., Jan 2 2017, In: Journal of Personality Assessment. 99, 1, p. 78-82 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Personality
  • Psychotic Disorders
  • State Hospitals
  • Self Report
  • Inpatients
  2 Scopus citations

• What's new in our understanding of schizophrenia

  McEvoy, J. P., Feb 2017, In: Psychiatric Times. 34, 2

  Research output: Contribution to journal › Article › peer-review
• 2016

  A guide to the management of clozapine-related tolerability and safety concerns

  Citrome, L., McEvoy, J. P. & Saklad, S. R., Sep 1 2016, In: Clinical Schizophrenia and Related Psychoses. 10, 3, p. 163-177D

  Research output: Contribution to journal › Review article › peer-review

  • Clozapine
  • Agranulocytosis
  • Safety
  • Sialorrhea
  • Enuresis
  36 Scopus citations

• Brexpiprazole for the treatment of schizophrenia: A review of this novel serotonin-dopamine activity modulator

  McEvoy, J. P. & Citrome, L., Dec 1 2016, In: Clinical Schizophrenia and Related Psychoses. 9, 4, p. 177-186 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • brexpiprazole
  • Serotonin
  • Dopamine
  • Schizophrenia
  • Placebos
  15 Scopus citations

• Cost-effectiveness of long-acting injectable paliperidone palmitate versus haloperidol decanoate in maintenance treatment of schizophrenia

  Rosenheck, R. A., Leslie, D. L., Sint, K. J., Lin, H., Li, Y., McEvoy, J. P., Byerly, M. J., Hamer, R. M., Swartz, M. S. & Stroup, T. S., Oct 1 2016, In: Psychiatric Services. 67, 10, p. 1124-1130 7 p.

  Research output: Contribution to journal › Article › peer-review

  • haloperidol decanoate
  • Paliperidone Palmitate
  • Cost-Benefit Analysis
  • Schizophrenia
  • Quality-Adjusted Life Years
  8 Scopus citations

• Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia

  Emsley, R., Fleischhacker, W. W., Galderisi, S., Halpern, L. J., McEvoy, J. P. & Schooler, N. R., Sep 9 2016, In: BMJ (Clinical research ed.). 354, p. i4728

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• The RAISE connection program: Psychopharmacological treatment of people with a first episode of schizophrenia

  Kreyenbuhl, J. A., Medoff, D. R., McEvoy, J. P., Smith, T. E., Hackman, A. L., Nossel, I. R., Dixon, L. B., Essock, S. M. & Buchanan, R. W., Dec 1 2016, In: Psychiatric Services. 67, 12, p. 1300-1306 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Antipsychotic Agents
  • Schizophrenia
  • Appointments and Schedules
  • Psychiatry
  • Decision Making
  9 Scopus citations

• To the Editor

  McEvoy, J. P., Oct 1 2016, In: JAMA Psychiatry. 73, 10, p. 1097-1098 2 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations
• 2015

  Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients with Persistent Symptoms

  Kelly, D. L., Sullivan, K. M., McEvoy, J. P., McMahon, R. P., Wehring, H. J., Gold, J. M., Liu, F., Warfel, D., Vyas, G., Richardson, C. M., Fischer, B. A., Keller, W. R., Koola, M. M., Feldman, S. M., Russ, J. C., Keefe, R. S. E., Osing, J., Hubzin, L., August, S., Walker, T. M. & 1 others, Buchanan, R. W., Aug 11 2015, In: Journal of Clinical Psychopharmacology. 35, 4, p. 374-381 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Minocycline
  • Clozapine
  • Schizophrenia
  • Brief Psychiatric Rating Scale
  • Placebos
  56 Scopus citations

• Asenapine once daily versus twice daily: Impact on patient acceptance in a randomized, open-label, 14-day clinical trial

  Sun, X., Hamer, R. & McEvoy, J., Jul 1 2015, In: Journal of Clinical Psychiatry. 76, 7, p. 992-993 2 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Randomized trial of the effect of four second-generation antipsychotics and one first-generation antipsychotic on cigarette smoking, alcohol, and drug use in chronic schizophrenia

  Mohamed, S., Rosenheck, R. A., Lin, H., Swartz, M., McEvoy, J. P. & Stroup, S., Jul 1 2015, In: Journal of Nervous and Mental Disease. 203, 7, p. 486-492 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Cigarette Smoking
  • Antipsychotic Agents
  • Schizophrenia
  • Alcohols
  • Pharmaceutical Preparations
  13 Scopus citations

• Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study

  Mori, N., McEvoy, J. P. & Miller, B. J., Dec 1 2015, In: Schizophrenia Research. 169, 1-3, p. 30-35 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Clinical Trials, Phase I
  • Adipokines
  • Leukocyte Count
  • Metabolic Syndrome
  • Antipsychotic Agents
  17 Scopus citations
• 2014

  Antipsychotic medications for schizophrenia-reply

  Stroup, T. S., McEvoy, J. P. & Hamer, R. M., Oct 8 2014, In: JAMA - Journal of the American Medical Association. 312, 14, 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: A 6-month, open-label, extension study

  Citrome, L., Weiden, P. J., McEvoy, J. P., Correll, C. U., Cucchiaro, J., Hsu, J. & Loebel, A., Aug 2014, In: CNS spectrums. 19, 4, p. 330-339 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Lurasidone Hydrochloride
  • Antipsychotic Agents
  • Schizophrenia
  • Psychotic Disorders
  • Psychomotor Agitation
  32 Scopus citations

• Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: A randomized clinical trial

  McEvoy, J. P., Byerly, M., Hamer, R. M., Dominik, R., Swartz, M. S., Rosenheck, R. A., Ray, N., Lamberti, J. S., Buckley, P. F., Wilkins, T. M. & Stroup, T. S., May 21 2014, In: JAMA - Journal of the American Medical Association. 311, 19, p. 1978-1986 9 p.

  Research output: Contribution to journal › Article › peer-review

  • haloperidol decanoate
  • Paliperidone Palmitate
  • Schizophrenia
  • Antipsychotic Agents
  • Randomized Controlled Trials
  81 Scopus citations

• Quantitative levels of aripiprazole parent drug and metabolites in urine

  McEvoy, J., Millet, R. A., Dretchen, K., Morris, A. A., Corwin, M. J. & Buckley, P., Dec 2014, In: Psychopharmacology. 231, 23, p. 4421-4428 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Aripiprazole
  • Parents
  • Urine
  • dehydroaripiprazole
  • Pharmaceutical Preparations
  6 Scopus citations
• 2013

  Clozapine for self-injurious behavior in individuals with borderline personality disorder

  Zarzar, T. & McEvoy, J., Oct 2013, In: Therapeutic Advances in Psychopharmacology. 3, 5, p. 272-274 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Self-Injurious Behavior
  • Borderline Personality Disorder
  • Clozapine
  • Aggression
  • State Hospitals
  10 Scopus citations

• Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: A randomized, 6-week, open-label study

  McEvoy, J. P., Citrome, L., Hernandez, D., Cucchiaro, J., Hsu, J., Pikalov, A. & Loebel, A., Feb 2013, In: Journal of Clinical Psychiatry. 74, 2, p. 170-179 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Lurasidone Hydrochloride
  • Psychotic Disorders
  • Antipsychotic Agents
  • Schizophrenia
  • Treatment Failure
  48 Scopus citations

• Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia

  Jarskog, L. F., Dong, Z., Kangarlu, A., Colibazzi, T., Girgis, R. R., Kegeles, L. S., Barch, D. M., Buchanan, R. W., Csernansky, J. G., Goff, D. C., Harms, M. P., Javitt, D. C., Keefe, R. S., McEvoy, J. P., McMahon, R. P., Marder, S. R., Peterson, B. S. & Lieberman, J. A., Jun 2013, In: Neuropsychopharmacology. 38, 7, p. 1245-1252 8 p.

  Research output: Contribution to journal › Article › peer-review

  • davunetide
  • N-acetylaspartate
  • Choline
  • Prefrontal Cortex
  • Schizophrenia
  50 Scopus citations

• Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial

  Stroup, T. S., Byerly, M. J., Nasrallah, H. A., Ray, N., Khan, A. Y., Lamberti, J. S., Glick, I. D., Steinbook, R. M., McEvoy, J. P. & Hamer, R. M., May 2013, In: Schizophrenia Research. 146, 1-3, p. 190-195 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Aripiprazole
  • Quetiapine Fumarate
  • Olanzapine
  • Risperidone
  • Metabolic Syndrome
  19 Scopus citations

• High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: The ZEBRAS study

  Goff, D. C., McEvoy, J. P., Citrome, L., Mech, A. W., Bustillo, J. R., Gil, R., Buckley, P., Manschreck, T. C., Achtyes, E. D. & Macklin, E. A., Aug 1 2013, In: Journal of Clinical Psychopharmacology. 33, 4, p. 485-490 6 p.

  Research output: Contribution to journal › Article › peer-review

  • ziprasidone
  • Schizophrenia
  • Serum
  • Blood Pressure
  • Psychotic Disorders
  11 Scopus citations

• Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics

  McEvoy, J. P., Baillie, R. A., Zhu, H., Buckley, P. F., Keshavan, M. S., Nasrallah, H. A., Dougherty, G. G., Yao, J. K. & Kaddurah-Daouk, R., Jul 24 2013, In: PloS one. 8, 7, e68717.

  Research output: Contribution to journal › Article › peer-review

  • schizophrenia
  • antipsychotics
  • Antipsychotic Agents
  • Unsaturated Fatty Acids
  • Schizophrenia
  71 Scopus citations

• Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder

  Jarskog, L. F., Hamer, R. M., Catellier, D. J., Stewart, D. D., LaVange, L., Ray, N., Golden, L. H., Lieberman, J. A., Stroup, T. S., Adler, L., Burnie, G., Barber, M., Byerly, M., Canive, J. M., Glick, I., Henderson, D. C., Lamberti, J. S., Khan, A., McEvoy, J. P., Meltzer, H. & 6 others, Miller, A., Miller, D. D., Nasrallah, H. A., Olson, S., Patel, J. K. & Saltz, B. L., Sep 1 2013, In: American Journal of Psychiatry. 170, 9, p. 1032-1040 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Metformin
  • Psychotic Disorders
  • Overweight
  • Weight Loss
  • Schizophrenia
  92 Scopus citations

• Persistent infection with neurotropic herpes viruses and cognitive impairment

  Watson, A. M. M., Prasad, K. M., Klei, L., Wood, J. A., Yolken, R. H., Gur, R. C., Bradford, L. D., Calkins, M. E., Richard, J., Edwards, N., Savage, R. M., Allen, T. B., Kwentus, J., McEvoy, J. P., Santos, A., Wiener, H. W., Go, R. C. P., Perry, R. T., Nasrallah, H. A., Gur, R. E. & 2 others, Devlin, B. & Nimgaonkar, V. L., May 2013, In: Psychological Medicine. 43, 5, p. 1023-1031 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Cognitive Dysfunction
  • Viruses
  • Human Herpesvirus 1
  • Encephalitis
  • Cytomegalovirus
  30 Scopus citations

• Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects

  Wiener, H., Klei, L., Calkins, M., Wood, J., Nimgaonkar, V., Gur, R., DiAnne Bradford, L., Richard, J., Edwards, N., Savage, R., Kwentus, J., Allen, T., McEvoy, J. P., Santos, A., Gur, R., Devlin, B. & Go, R., Mar 2013, In: Schizophrenia Bulletin. 39, 2, p. 464-471 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Schizophrenia
  • Spatial Processing
  • Population Control
  • Mental Status and Dementia Tests
  • Individuality
  9 Scopus citations
• 2012

  Associations between purine metabolites and clinical symptoms in schizophrenia

  Yao, J. K., Condray, R., Dougherty, G. G., Keshavan, M. S., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah-Daouk, R. & Reddy, R. D., Aug 14 2012, In: PloS one. 7, 8, e42165.

  Research output: Contribution to journal › Article › peer-review

  • schizophrenia
  • Metabolites
  • purine
  • purines
  • signs and symptoms (animals and humans)
  20 Scopus citations